1810 Journal of Natural Products, 2008, Vol. 71, No. 11
Mokrini et al.
Experimental Section
at room temperature. The reaction was quenched with H2O, and then
the mixture was extracted with Et2O (3 × 25 mL). The combined ether
extracts were dried over anhydrous MgSO4. The products were purified
using reversed-phase HPLC (Merck Purospher Star RP-18e 5 µm; 4.6
× 250 mm; 1 mL/min), with H2O/MeCN (20:80, v/v) as eluent, to
yield the pure alcohol 1a (2.1 mg).
General Experimental Procedures. Optical rotations were measured
on a Perkin-Elmer 343 polarimeter, using a 10 cm microcell. CD spectra
were obtained on a Jasco J-810 spectrophotometer. IR spectra were
recorded with a Jasco model J-410 FT-IR spectrometer as KBr plates
(films). 1D and 2D NMR spectra were obtained at 400 and 100 MHz
for 1H and 13C, respectively, on a Bruker Avance 400 MHz NMR
spectrometer in CDCl3. All chemical shifts were referenced to the
residual solvent peak observed at δH 7.26 and δC 77.0. High-resolution
mass spectra were carried out on an electrospray QTOF spectrometer
(Applied Biosystems, Model QStar). HPLC isolations were performed
using a Varian model Prostar 210 pump with RI monitoring (Varian
RI-4).
Plant Material. The marine brown alga Cystoseira baccata was
collected by hand at Sidi Bouzid near El Jadida on the Moroccan
Atlantic coast in December 2005 and was identified by two of the
authors (M.B.M. and M.D.). A voucher specimen is available from
G.C. as collection number CB-EJ-12/05.
Alcohol 1a: colorless oil; 1H NMR (CDCl3, 400 MHz) δH 6.56 (1H,
d, J ) 3.0 Hz, H-5′), 6.52 (1H, d, J ) 3.0 Hz, H-3′), 5.33 (1H, t, J )
7.0 Hz, H-2), 3.81 (1H, s, H-12), 3.73 (3H, s, H-4′OMe), 3.33 (2H,
brd, J ) 7.0 Hz, H-1), 3.12 (1H, d, J ) 14.5 Hz, H-4a), 2.92 (1H, d,
J ) 14.5 Hz, H-14a), 2.54 (1H, d, J ) 14.5 Hz, H-4b), 2.22 (3H, s,
H-6′Me), 2.12 (1H, d, J ) 14.5 Hz, H-14b), 2.05 (1H, m, H-10a), 1.95
(1H, d, J ) 17.0 Hz, H-6a), 1.83 (1H, d, J ) 17.0 Hz, H-6b), 1.74
(2H, m, H-9), 1.64 (3H, s, H-20), 1.54 (1H, m, H-8a), 1.39 (1H, m, H
8b), 1.30 (3H, s, H-17), 1.24 (1H, m, H-10b), 1.19 (3H, s, H-16), 0.97
(3H, s, H-19), 0.72 (3H, s, H-18); 13C NMR (CDCl3, 100 MHz) δC
153.1 (C, C-4′), 146.3 (C, C-1′), 135.9 (C, C-3), 135.4 (C, C-5), 129.3
(C, C-13), 127.3 (C, C-2′), 125.0 (C, C-6′), 123.6 (CH, C-2), 114.0
(CH, C-5′), 112.8 (CH, C-3′), 78.0 (CH, C-12), 71.5 (C, C-15), 55.6
(CH3, C-OMe), 47.1 (CH2, C-14), 46.7 (C, C-11), 44.9 (CH2, C-4),
41.1 (CH2, C-6), 40.8 (C, C-7), 36.7 (CH2, C-8), 31.5 (CH3, C-17),
30.0 (CH2, C-10), 29.9 (CH2, C-1), 28.7 (CH3, C-16), 24.8 (CH3, C-19),
22.4 (CH3, C-18), 19.1 (CH2, C-9), 16.2 (CH3, C-6’Me), 15.9 (CH3,
C-20).
Extraction and Purification. The shade-dried material (268 g dry
wt) was ground and extracted with mixtures of CHCl3/MeOH (2:1 then
1:1 and finally 1:2, v/v) at room temperature. The concentrated extracts
were combined and partitioned in a mixture of MeOH/CHCl3/H2O (4:
3:1, v/v/v) to yield, after solvent removal, 6.7 g of a dark brown
lipophilic extract. This extract was subjected to CC on silica gel (Si60,
40-63 µm, Merck) with a solvent gradient from n-hexane to EtOAc
and then from EtOAc to MeOH. The fraction eluting with 50% EtOAc
in n-hexane was further purified by repeated semipreparative HPLC
(Merck Purospher Star RP-18e 5 µm; 10 × 250 mm; 3 mL/min) using
H2O/MeCN (15:85, v/v) to afford five new compounds, 1 (9.8 mg), 3
(3.1 mg), 4 (3.7 mg), 5 (9.1 mg), and 7 (3.4 mg). From the fraction
eluted with EtOAC/n-hexane (60:40, v/v), two new metabolites, 2 (4.6
mg) and 6 (1.2 mg), were also purified by reversed-phase HPLC with
H2O/MeCN (20:80, v/v) as eluent.
Preparation of S- and R-MTPA Ester Derivatives of Compound
1a. Both (S)- and (R)-MTPA esters of 1a (1aS, 1aR) were obtained by
treatment of 1a (1.0 mg) with (R)- and (S)-MTPA chlorides (10 µL) in
dry pyridine (0.5 mL) catalyzed with DMAP and stirred at room
temperature overnight. The MTPA esters were purified using analytical
HPLC (Merck Purospher Star RP-18e 5 µm; 4.6 × 250 mm; 1 mL/
min), with H2O/MeCN (10:90, v/v) as eluent.
Selected signals of 1aS: 1H NMR (CDCl3, 400 MHz) δΗ 1.591 (H-
17), 1.373 (H-16), 0.614 (H-19), 0.462 (H-18). Selected signals of 1aR:
1H NMR (CDCl3, 400 MHz) δΗ 1.510 (H-17), 1.340 (H-16), 0.720
(H-19), 0.628 (H-18). ∆δH(1aS - 1aR): H-17, +0.081 ppm; H-16,
+0.033 ppm; H-19, -0.106 ppm; H-18, -0.166 ppm.
Compound 1: clear yellow oil; [R]25 +83 (c 0.1, MeOH); UV
D
(EtOH) λmax 300 nm (ε 2030), 330 nm (ε 520); IR (film) νmax 3415,
2968, 2931, 2881, 1658, 1604, 1484, 1460, 1379, 1354, 1199, 1144,
1060, 1010 cm-1
;
13C and H NMR (400 MHz, CDCl3), see Tables
1
Reduction of Compound 5 into the Corresponding Alcohol 5a.
A sample of 5 (5 mg) was treated as described above for compound 1.
Usual workup followed by reversed-phase HPLC afforded 5a (2.3 mg).
Alcohol 5a: colorless oil; 1H NMR (CDCl3, 400 MHz) δΗ 3.77 (1H,
brs, H-12), 2.83 (1H, d, J ) 14.5 Hz, H-14a), 2.08 (1H, d, J ) 14.5
Hz, H-14b), 2.05 (1H, d, J ) 17.5 Hz, H-6a), 2.04 (1H, m, H-10a),
1.91 (1H, d, J ) 17.5 Hz, H-6b), 1.76 (2H, m, H-9), 1.57 (1H, m,
H-8a), 1.42 (1H, m, H 8b), 1.66 (3H, s, H-4), 1.32 (3H, s, H-17), 1.27
(1H, m, H-10b), 1.20 (3H, s, H-16), 1.00 (3H, s, H-19), 0.75 (3H, s,
H-18); 13C NMR (CDCl3, 100 MHz) δC 134.5 (C, C-5), 126.9 (C, C-13),
78.5 (CH, C-12), 71.7 (C, C-15), 47.6 (CH2, C-14), 47.0 (C, C-11),
43.9 (CH2, C-6), 41.2 (C, C-7), 36.8 (CH2, C-8), 31.8 (CH3, C-17),
30.1 (CH2, C-10), 28.7 (CH3, C-16), 25.0 (CH3, C-19), 22.5 (CH3,
C-18), 21.4 (CH3, C-4), 19.3 (CH2, C-9).
1,2; HRESIMS m/z 463.2812 [M + Na]+ (calcd for C28H40O4Na,
463.2824).
Compound 2: clear yellow oil; [R]25 +28 (c 0.1, MeOH); UV
D
(EtOH) λmax 300 nm (ε 2290); IR (Film) νmax 3432, 3203, 2950, 2877,
1694, 1482, 1453, 1380, 1331, 1224, 1186, 1139, 1054 cm-1 13C and
;
1H NMR (400 MHz, CDCl3), see Tables 1 and 2; HRESIMS m/z
481.2904 [M + Na]+ (calcd for C28H42O5Na, 481.2930).
Compound 3: clear yellow oil; [R]25 -6 (c 0.1, MeOH); CD
D
(MeOH) λmax ∆ε274 -34.55; UV (EtOH) λmax 290 nm (ε 3070), 330
nm (ε 2240); IR (film) νmax 3421, 2966, 2927, 1657, 1601, 1469, 1377,
1193, 1143, 1059 cm-1 13C and 1H NMR (400 MHz, CDCl3), see
;
Tables 1 and 2; HRESIMS m/z 479.2767 [M + Na]+ (calcd for
C28H40O5Na, 479.2773).
Compound 4: clear yellow oil; [R]25 +65 (c 0.1, MeOH); CD
Preparation of S- and R-MTPA Ester Derivatives of Compound
5a. A solution of pure compound (2.3 mg) was divided into two parts,
then transferred into clean NMR tubes and dried under the stream of
N2 gas. Deuterated pyridine (0.6 mL) and (S)-(-)-MTPACl (4 µL) or
(R)-(+)-MTPACl (4 µL) were added successively to the NMR tube
under a N2 gas stream, and the tube was carefully shaken to mix the
sample and MTPA chloride evenly. The reaction in the NMR tubes
D
(MeOH) λmax ∆ε274 +2.50; UV (EtOH) λmax 275 nm (ε 1740), 330 nm
(ε 970); IR (film) νmax 3439, 2965, 2926, 1656, 1602, 1468, 1376, 1196,
1146, 1060 cm-1
;
13C and H NMR (400 MHz, CDCl3), see Tables 1
1
and 2; HRESIMS m/z 479.2735 [M + Na]+ (calcd for C28H40O5Na,
479.2773).
Compound 5: clear yellow oil; [R]25 +53 (c 0.1, MeOH); UV
D
1
was monitored by H NMR and was completed in approximately 6 h
(EtOH) λmax 280 nm (ε 1070); IR (film) νmax 3428, 2966, 2930, 2879,
1652, 1612, 1450, 1378, 1150 cm-1 13C and 1H NMR (400 MHz,
;
for the (S)-MTPA ester 5aS and 48 h for the (R)-MTPA ester 5aR.
Selected signals of 5aS: 1H NMR (C5D5N, 400 MHz) δΗ 1.711 (H-
4), 1.694 (H-17), 1.670 (H-16), 1.206 (H-19), 0.715 (H-18). Selected
CDCl3), see Tables 1 and 2; HRESIMS m/z 273.1822 [M + Na]+ (calcd
for C16H26O2Na, 273.1830).
1
Compound 6: clear yellow oil; [R]25D +7 (c 0.1, MeOH); IR (film)
νmax 3402, 2970, 2923, 1718, 1680, 1608, 1456, 1378, 1314, 1126,
signals of 5aR: H NMR (C5D5N, 400 MHz) δΗ 1.706 (H-2), 1.496
(H-17), 1.423 (H-16), 1.279 (H-19), 0.812 (H-18). ∆δH(5aS - 5aR):
H-4, +0.005 ppm; H-17, +0.198 ppm; H-16, +0.247 ppm; H-19,
-0.073 ppm; H-18, -0.097 ppm.
1038 cm-1 13C and 1H NMR (400 MHz, CDCl3), see Tables 1 and 2;
;
HRESIMS m/z 315.1919 [M + Na]+ (calcd for C18H28O3Na, 315.1936).
Compound 7: clear yellow oil; [R]25 -11 (c 0.1, MeOH); UV
Biological Assays. Biological assays of the compounds were
performed toward bacteria (marine and terrestrial), microalgae, mac-
roalgae, and marine invertebrates. Toxicity was checked against larvae
of sea urchins and oysters. All the compounds were tested on a range
of concentrations from 0.5 to 100 µg/mL (0.5, 1, 2.5, 5, 10, 25, 50,
and 100 µg/mL). Each experiment and controls were run in six replicates
and using two batches of organisms.
D
(EtOH) λmax 350 nm (ε 920), 270 nm (ε 350); IR (film) νmax 3433,
2966, 2931, 2879, 1715, 1684, 1607, 1547, 1449, 1376, 1332, 1277,
1258, 1181, 1130 cm-1 13C and 1H NMR (400 MHz, CDCl3), see
;
Tables 1 and 2; HRESIMS m/z 297.1807 [M + Na]+ (calcd for
C18H26O2Na, 297.1830).
Reduction of Compound 1 into the Corresponding Alcohol 1a.
Reduction of 1 (5 mg) was conducted in MeOH (10 mL) with an excess
of NaBH4 (10 mg), and the solution was then allowed to stand overnight
Antibacterial Assays. The compounds were tested for inhibitory
activities against three strains of marine bacteria [Pseudoalteromonas